University of Toronto Grants Exclusive Rights to Wound Healing Technology to Cardium Therapeutics / - Deal signed less than 18 months after MaRS Innovation takes the lead on commercializing the U of T technology. - Cardium deal validates MaRS Innovatio
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.